1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Parenteral Nutrition Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Parenteral Nutrition Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Parenteral Nutrition Market Regional Analysis
6.2 Middle East & Africa Parenteral Nutrition Market Revenue 2020-2030 (US$ Million)
6.3 Middle East & Africa Parenteral Nutrition Market Forecast Analysis
7. Middle East & Africa Parenteral Nutrition Market Analysis – by Nutrient Type
7.1 Single Dose Amino Acid Solution
- 7.1.1 Overview
- 7.1.2 Single Dose Amino Acid Solution: Middle East & Africa Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Parenteral Lipid Emulsion
- 7.2.1 Overview
- 7.2.2 Parenteral Lipid Emulsion: Middle East & Africa Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Carbohydrates
- 7.3.1 Overview
- 7.3.2 Carbohydrates: Middle East & Africa Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Trace Elements
- 7.4.1 Overview
- 7.4.2 Trace Elements: Middle East & Africa Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.5 Vitamins and Minerals
- 7.5.1 Overview
- 7.5.2 Vitamins and Minerals: Middle East & Africa Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Middle East & Africa Parenteral Nutrition Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Middle East & Africa Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Clinics
- 8.2.1 Overview
- 8.2.2 Clinics: Middle East & Africa Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Middle East & Africa Parenteral Nutrition Market – Middle East and Africa Analysis
9.1 Overview
9.2 Middle East and Africa
- 9.2.1 Middle East & Africa Parenteral Nutrition Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 9.2.1.1 Middle East & Africa Parenteral Nutrition Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 South Africa:
Middle East & Africa Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.1.1 South Africa: Middle East & Africa Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.2.1.1.2 South Africa: Middle East & Africa Parenteral Nutrition Market Breakdown, by End User
- 9.2.1.2 Saudi Arabia:
Middle East & Africa Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.2.1 Saudi Arabia: Middle East & Africa Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.2.1.2.2 Saudi Arabia: Middle East & Africa Parenteral Nutrition Market Breakdown, by End User
- 9.2.1.3 UAE:
Middle East & Africa Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.3.1 UAE: Middle East & Africa Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.2.1.3.2 UAE: Middle East & Africa Parenteral Nutrition Market Breakdown, by End User
- 9.2.1.4 Rest of Middle East and Africa:
Middle East & Africa Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Parenteral Nutrition Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 ICU Medical Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Grifols SA
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Pfizer Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Otsuka Pharmaceuticals Co Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 B Braun SE
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Fresenius Kabi AG
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Aculife Healthcare Pvt Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Vifor Pharma Management AG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations